You have to go way back to November of 2022 when Vitalhub became one of the first companies to ever receive a four star review. They traded at around $2.25 per share at that time and I also picked up some shares shortly afterwards. I exited for approximately a 200% gain back in the middle of 2024, only to see the stock to continue on a much higher ascent, peaking at close to $15 at one point last summer.
Fast forward to the spring thaw of 2026 and Vitalhub’s valuation has melted to the tune of 54% in the past eight months, leaving many in this unenviable position:
For a long time, I’ve felt Vitalhub was been trading well ahead of it’s fair valuation. But at some point this downward slide has to start to reverse. Right?
When I first glanced at their final financials of the 2025 fiscal year I thought we could be nearing that time of price recovery. We are now a week later and the stock is down 8%. Has it reached the bottom? Let’s take the first deep dive I’ve performed here in some time.